Women's reports of persistent, recent-onset symptoms linked to ovarian cancer (abdominal or pelvic pain, difficulty eating or feeling full quickly, abdominal bloating) when combined with the CA125 blood test may improve early detection of ovarian cancer.
Individuals participating in a clinical trial hope to benefit personally from the research but also understand they are contributing to society.